What does Hankang Capital invest in?
Hankang Capital invests most often at Series B and Series C (100% of the rounds on record), in sectors such as Venture Capital & Private Equity.

China · Investor
Last cheque observed Aug 2026; 2 cheques on record.
Growth equityDeploying now
Follow Hankang Capital and see its new cheques in your feed. Start following
1 cheques in the last 12 months
Mostly Series B and Series C: 100% of its rounds
Every round we can evidence, newest first2 appearances
1 round
1 round
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The investors most often in the same rounds as Hankang Capital. A count of rooms they were both in, not a relationship either has claimed.
The latest companies Hankang Capital put money into.
Hankang Capital invests most often at Series B and Series C (100% of the rounds on record), in sectors such as Venture Capital & Private Equity.
2 investments on record, 1 of them in the last 12 months. The most recent was in Aug 2026.
Its most recent investments on record: AusperBio Therapeutics (Series C, Aug 2026) and AusperBio (Series B, May 2025).
The median round it joins is $85M.
Yes: it is actively investing, with 1 investments in the last 12 months.
Most often CDH Investments (2 rounds together), Qiming Venture Partners (2 rounds together) and Sherpa Capital (2 rounds together).
Hankang Capital is a growth equity firm based in Shanghai, China.
From 3 articles and filings naming it in a round, public registers and its own website, checked and rebuilt every night.
Find the investors who back rounds like yours, and keep every conversation on one fundraising board.
Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it